Likewise, patients in T2 stage with low SOCS2 expression had even poorer prognosis than T3 patients with high SOCS2 expression (Fig. 3E left panel), suggesting that SOCS2 is not an insignificant bystander and may play a vital role in the determination of the clinical outcome of HCC patients. Here, SOCS2 is linked to hepatocellular carcinoma.